Home About Us

Board of Directors

Mr. Mark Saldanha - Promoter and Managing Director
Mr. Mark Saldanha
Promoter and Managing Director

Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company. Under his able and dynamic leadership, Marksans has grown rapidly to attain newer milestones and the highest level of performance. He is the principal architect for the progress of the organization.

Mr. Mark Saldanha is a science graduate with more than two decades of experience across business and technical functions. He is well versed with the overall management of the company and possesses vast amount of hands-on experience in marketing, production and finance.

His business acumen, entrepreneurial zeal, organizational skills and managerial abilities have enabled Marksans to grow leaps and bounds and spread its wings across the globe.

Mrs. Sandra Saldanha - Whole-Time Director
Mrs. Sandra Saldanha
Whole-Time Director

Mrs. Sandra Saldanha has a Master Degree in Arts (Sociology). She has vast experience in the field of Human Resource Management, Business Development, Projects and Supply Chain Management. Mrs. Saldanha is also a Director in Marksans Pharma (UK) Limited.

Mr. Varddhman Vikramaditya Jain - Whole-Time Director
Mr. Varddhman Vikramaditya Jain
Whole-Time Director

Mr. Varddhman Vikramaditya Jain is M. Pharm (Pharmaceuticals). He is a Pharmaceutical professional with technical background who has worked with various multinational organizations. He is specialized in the area of manufacturing, quality R&D, compliance & regulatory affairs both for API and finished dosage from manufacturing. In a carer span of 25 years, Mr. Jain has successfully handeled several regulatory inspection including SFDA, MHRA, PMDA Japan and WHO with good leadership and sound technical knowledge. He has given the organizations very sound systems which are capble of standing up to very tough regulatory inspections of recent years.

Mr. Seetharama Raju Buddharaju - Director
Mr. Seetharama Raju Buddharaju
Director

Mr. Seetharama Raju Buddharaju is a Director of the company and has more than 35 years of experience in Sales Management, Marketing and Business Administration. He holds a B.Sc., a PGDBM and a PGDMSM. For over 22 years, he has successfully handled various senior sales management roles for Parke-Davis and Pfizer.

Dr. Meena Rani Surana - Independent Director
Dr. Meena Rani Surana
Independent Director

Dr. Meena Rani Surana is a pharma professional. She is Bachelor of Pharmacy and Ph.D in Pharmaceutics from Indian Institute of Technology, BHU, Varanasi, India and has done a Post Doctoral Fellowship in Pharmaceutics from Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA. She has about 27 years of experience in pharmaceutical regulatory affairs, quality assurance, formulation and pre-formulation.

Mr. Digant Mahesh Parikh - Independent Director
Mr. Digant Mahesh Parikh
Independent Director

Mr. Digant Mahesh Parikh is a Master of Business Administration in Finance. He has over 23 years of experience in diverse industries in areas of Corporate Finance, Strategic Planning and Business Set-up & Scale up. He is a visiting faculty at leading management schools for the subjects in the field of Corporate & Retail Finance and Banking.

Mr. Abhinna Sundar Mohanty - Whole-time Director
Mr. Abhinna Sundar Mohanty
Independent Director

Mr. Abhinna Sundar Mohanty is an M.Sc. in Mathematics. He has 39 years of experience in the pharmaceutical industry. He started his career with Alembic and went on to build his career through every cadre in sales and marketing department of pharma industry. During his career, he was engaged in sales, marketing, business development and business strategy for over 27 years in pharma industry. He was instrumental in globalising branded business for pharma sector in most part of the world.

Dr. Sunny Sharma - Non-executive Director
Dr. Sunny Sharma
Non-executive Director

Dr. Sunny Sharma is an MBA and MBBS. He is a Senior Managing Director of OrbiMed Asia. Previously, he was with Investor Growth Capital (IGC), the investment arm of Investor AB in North America, and before that with Easton Capital in New York. Earlier in his career, Dr. Sharma worked in the healthcare investment banking group of Lehman Brothers in London.